Home Dermatology PDF: A Novel Fixed Dose Triple Combination Therapy (IDP-126) for Moderate to Severe Acne
- You cannot add another "PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea" to your cart. View cart
PDF: A Novel Fixed Dose Triple Combination Therapy (IDP-126) for Moderate to Severe Acne
$1.99
PDF Download: IDP-126 is a novel fixed-dose topical gel combining clindamycin, benzoyl peroxide, and adapalene for moderate to severe acne. Approved by the FDA and Health Canada, it showed superior efficacy over dual therapies in phase 2 and 3 trials, with strong safety and tolerability outcomes.
Read online:
A Novel Fixed Dose Triple Combination Therapy (IDP-126) for Moderate to Severe Acne